Zacks Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,146
| Closed | -$1.28M | – | 732 |
|
|
2025
Q1 | $1.28M | Buy |
20,146
+703
| +4% | +$44.7K | 0.01% | 379 |
|
|
2024
Q4 | $1.52M | Buy |
19,443
+2,522
| +15% | +$197K | 0.01% | 369 |
|
|
2024
Q3 | $1.36M | Buy |
16,921
+1,740
| +11% | +$140K | 0.01% | 381 |
|
|
2024
Q2 | $1.26M | Buy |
15,181
+1,473
| +11% | +$122K | 0.01% | 343 |
|
|
2024
Q1 | $1.17M | Buy |
13,708
+2,884
| +27% | +$246K | 0.01% | 385 |
|
|
2023
Q4 | $926K | Sell |
10,824
-1,102
| -9% | -$94.2K | 0.01% | 386 |
|
|
2023
Q3 | $1.07M | Buy |
11,926
+993
| +9% | +$89K | 0.01% | 364 |
|
|
2023
Q2 | $931K | Buy |
+10,933
| New | +$931K | 0.01% | 384 |
|
|
2020
Q4 | – | Sell |
-7,154
| Closed | -$624K | – | 544 |
|
|
2020
Q3 | $624K | Sell |
7,154
-5,740
| -45% | -$501K | 0.01% | 379 |
|
|
2020
Q2 | $1.16M | Sell |
12,894
-1,668
| -11% | -$149K | 0.03% | 278 |
|
|
2020
Q1 | $1.45M | Sell |
14,562
-670
| -4% | -$66.8K | 0.04% | 242 |
|
|
2019
Q4 | $1.75M | Sell |
15,232
-2,663
| -15% | -$306K | 0.03% | 296 |
|
|
2019
Q3 | $2.26M | Buy |
17,895
+7,906
| +79% | +$997K | 0.05% | 234 |
|
|
2019
Q2 | $1.2M | Buy |
+9,989
| New | +$1.2M | 0.02% | 373 |
|
|
2014
Q1 | – | Sell |
-13,246
| Closed | -$558K | – | 713 |
|
|
2013
Q4 | $558K | Sell |
13,246
-7,514
| -36% | -$317K | 0.02% | 347 |
|
|
2013
Q3 | $828K | Buy |
20,760
+1,088
| +6% | +$43.4K | 0.04% | 249 |
|
|
2013
Q2 | $813K | Buy |
+19,672
| New | +$813K | 0.04% | 247 |
|